Dosis dan Rute Pemberian Diuretik Loop pada Gagal Jantung Akut
DOI:
https://doi.org/10.55175/cdk.v45i6.769Keywords:
Diuretik loop, dosis, gagal jantung akut, rute pemberianAbstract
Gagal jantung akut adalah sindrom klinis yang ditandai dengan kongesti dan retensi cairan. Diuretik loop intravena merupakan terapi lini pertama gagal jantung akut, namun efektivitas dan keamanan terkait dosis dan rute pemberian obat masih tidak pasti. Tulisan ini membahas 2 episode gagal jantung dekompensasi akut pada pasien yang sama. Pada serangan pertama, diberikan furosemid bolus intravena dengan dosis sama dengan total dosis oral harian. Pada serangan kedua, diberikan furosemid bolus intravena 2,5 kali lebih besar dari total dosis oral harian. Didapatkan hasil klinis lebih baik dan lama rawatan lebih pendek pada episode kedua. Dosis diuretik loop harus disesuaikan berdasarkan klinis dan respons pasien serta riwayat terapi diuretik loop sebelumnya.
Acute heart failure is a clinical syndrome characterized by congestion and fluid retention. Intravenous loop diuretics are used as the first-line therapy, but there is still uncertainty on the effectiveness and safety in terms of dosage and drug administration. This report discusses two episodes of acute decompensated heart failure in the same patient. In the first episode, furosemide intravenous bolus was given at the same dose as the total daily oral dose. In the second episode, furosemide intravenous bolus was given 2.5 times larger than total daily oral dose. Better clinical outcomes and shorter length of stay in hospital were obtained in second case. Loop diuretic dose should be adjusted based on clinical and patient response and history of previous loop diuretic therapy.
Downloads
References
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2016;37:2129-200.
Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman tatalaksana gagal jantung. Jakarta: PERKI; 2015.
Felker GM, Mentz RJ. Diuretics and ultrafiltration in acute decompensated heart failure. JACC. 2012;59(24):2145-53.
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364(9):797–805.
Felker GM, O’Connor CM, Braunwald E. Loop diuretics in acute decompensated heart failure: Necessary? evil? a necessary evil? Circ Heart Fail. 2009;2(1):56-62.
Palazzuoli A, Ruocco G, Ronco C, McCullough. Loop diuretics in acute heart failure: Beyond the decongestive relief for the kidney. Critical Care. 2015;19:296-302.
Colucci WS. Treatment of acute decompensated heart failure: components of therapy [Internet]. 2017 Sep [cited 2017 Oct 20]. Available from: https://www.uptodate.com/contents/treatment-of-acute-decompensated-heart-failure-components-of-therapy
Friedman EA, Peter K. Diuretics and heart failure [Internet]. 2015 [cited 2017 Oct 21]. Available from: https://emedicine.medscape.com/article/2145340-overview#showall
Chiong JR, Cheung RJ. Loop diuretic therapy in heart failure: The need for solid evidence on a fluid issue. Clin. Cardiol. 2010;33(6):345-52.
Casu G, Merella P. Diuretic therapy in heart failure – Current approaches. European Cardiology Review. 2015;10(1):42–7.
Palazzuoli A, Pellegrini M, Ruocco G, Martini G, Franci B, Campagna MS, et al. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: A prospective randomized trial. Critical Care. 2014;18:134-43.
Palazzuoli A, Ruocco G, Vescovo G, Valle R, Somma SD, Nuti R. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIURAHF. ESC Heart Failure. 2017;4:479-86.
Aronson D, Burger AJ. The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail 2010;16(7):541-7
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.